Eddie Adams

Eddie Adams is the Chief Scientific Officer of Micronoma, Inc. At Micronoma he leads the development of the Oncobiota™ cell-free microbial DNA liquid biopsy assays for cancer detection. He received his PhD in Biological Chemistry in Peter Seeberger’s laboratory from the Massachusetts Institute of Technology and carried out postdoctoral work in innate immunity with Prof. Nir Hacohen at Harvard Medical School. His industrial research career has encompassed development and successful commercialization of products in nanotechnology, epigenetics, microbiome sample preparation solutions, and disease diagnostics for sepsis and cancer. Eddie is an inventor on 17 issued patents and numerous patent applications.